Faeth Therapeutics, Inc. (FTH) is currently trading at $25.0 with a Wall Street consensus price target of $54.5, implying potential upside of 118.0% over the next 12 months. 6 analysts currently cover FTH, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $60.0, while the most cautious has a target of $50.0.
FTH operates in the Healthcare sector with a market capitalisation of $644M. The stock is up 159.2% year-to-date and is currently trading near the upper end of its 52-week range of $6.33 – $36.76.
Other Healthcare stocks with comparable size and valuation.
Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.
Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.
StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.
View Full Rankings →